HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Ogris Selected Research

Caspases

11/2009Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Ogris Research Topics

Disease

2Residual Neoplasm
11/2009 - 01/2002
2Neoplasms (Cancer)
11/2009 - 01/2002
2Breast Neoplasms (Breast Cancer)
01/2002 - 08/2000
1Colonic Neoplasms (Colon Cancer)
11/2009
1Nausea
12/2004
1Vomiting
12/2004
1Abdominal Pain (Pain, Abdominal)
12/2004
1Appendicitis
12/2004
1Colorectal Neoplasms (Colorectal Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

1Keratin-18 (Keratin 18)IBA
11/2009
1Keratins (Keratin)IBA
11/2009
1Biomarkers (Surrogate Marker)IBA
11/2009
1CaspasesIBA
11/2009
1ProcalcitoninIBA
12/2004
1C-Reactive ProteinIBA
12/2004
1Biological ProductsIBA
01/2002
1ProlactinIBA
08/2000
1Pharmaceutical PreparationsIBA
08/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2009 - 08/2000
1Therapeutics
01/2002
1Lymph Node Excision (Lymph Node Dissection)
01/2002
1Immunotherapy
08/2000
1Autologous Transplantation
08/2000
1Stem Cell Transplantation
08/2000